<DOC>
	<DOCNO>NCT02309619</DOCNO>
	<brief_summary>Esophageal cancer ( EC ) eighth common cancer sixth lead cause cancer death worldwide . Minimally invasive esophagectomy ( MIE ) regard safe effective management resectable EC . Gastric tube consider ideal substitute resect esophagus lift neck anastomosis two different path — Trans-substernal trans-esophageal bed route . However , difference operative outcomes two path systematically describe . In study , clinical outcome include intra- post-operative status , morbidity complication , nutrition status , well quality life surgery evaluate , difference trans-substernal trans-esophageal bed group compare . The study might help individualization treatment EC .</brief_summary>
	<brief_title>Lifting Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path MIE</brief_title>
	<detailed_description>1 . Patients esophageal cancer ( EC ) histologically prove endoscopic biopsy , stag thoracicoabdominal compute tomography ( CT ) , endoluminal ultrasonography positron emission tomography ( PET ) surgery . The crucial test include barium meal , pulmonary function test , arterial blood gas analysis , cardiac ultrasonography , electrocardiogram treadmill test , well blood biochemistry examination also accomplish preoperatively . 2 . Patients meet clinical criterion ask sign consent form , divide randomly two group — trans-substernal group trans-esophageal bed group . Patients group undergo minimally invasive esophagectomy consist 4 step : ( 1 ) thoracoscopic esophageal mobilization follow mediastinal lymphadenectomy ; ( 2 ) laparoscopic gastric mobilization follow abdominal lymphadenectomy gastric tube construction ; ( 3 ) cervical esophageal mobilization transection ; ( 4 ) lift gastric tube neck gastro-esophageal anastomosis trans-substernal trans-esophageal bed path . The operative procedure two group similar except step 4 . 3 . Patients group followed-up regularly . Intra- post-operative status , morbidity complication , nutrition status , well quality life surgery evaluate , difference trans-substernal trans-esophageal bed group compare .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Histologically proven squamous cell carcinoma , adenocarcinoma undifferentiated carcinoma intrathoracic esophagus . Surgical resectable ( T14a , N03 , M0 ) . Age ≥ 18 ≤ 75 year . European Clinical Oncology Group ( ECOG ) performance status 0,1 2 . Written inform consent obtain Carcinoma cervical esophagus . Carcinoma gastroesophageal junction ( GEJ ) . Prior thoracic surgery trauma right hemithorax , previous disease may lead right pleural adhesion ( patient undergo open surgery instead minimally invasive esophagectomy ) . Dysfunction cardiorespiratory system surgical contraindication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>esophageal cancer</keyword>
	<keyword>esophagectomy</keyword>
	<keyword>quality life</keyword>
</DOC>